Sonoma pharmaceuticals to present at h.c. wainwright bioconnect virtual conference january 10-13, 2022

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions, today announced that it will be featured as a presenting company at the h.c. wainwright bioconnect conference. the conference is being held on january 10-13, 2022 virtually. amy trombly, ceo and jerry dvon
SNOA Ratings Summary
SNOA Quant Ranking